These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11239724)

  • 1. Relapse outcomes in a randomized trial of residential and day drug abuse treatment.
    Greenwood GL; Woods WJ; Guydish J; Bein E
    J Subst Abuse Treat; 2001 Jan; 20(1):15-23. PubMed ID: 11239724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of alternative planned durations of residential drug abuse treatment.
    McCusker J; Vickers-Lahti M; Stoddard A; Hindin R; Bigelow C; Zorn M; Garfield F; Frost R; Love C; Lewis B
    Am J Public Health; 1995 Oct; 85(10):1426-9. PubMed ID: 7573630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing day and residential drug abuse treatment: 18-month outcomes.
    Guydish J; Sorensen JL; Chan M; Werdegar D; Bostrom A; Acampora A
    J Consult Clin Psychol; 1999 Jun; 67(3):428-34. PubMed ID: 10369064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug abuse day treatment: a randomized clinical trial comparing day and residential treatment programs.
    Guydish J; Werdegar D; Sorensen JL; Clark W; Acampora A
    J Consult Clin Psychol; 1998 Apr; 66(2):280-9. PubMed ID: 9583331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Planned duration of residential drug abuse treatment: efficacy versus effectiveness.
    McCusker J; Bigelow C; Vickers-Lahti M; Spotts D; Garfield F; Frost R
    Addiction; 1997 Nov; 92(11):1467-78. PubMed ID: 9519490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clients entering drug abuse day treatment: 18-month outcomes.
    Guydish J; Werdegar D; Tajima B; Price M; Acampora A
    Am J Drug Alcohol Abuse; 1997 Feb; 23(1):99-114. PubMed ID: 9048150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of planned duration of residential drug abuse treatment on recovery and HIV risk behavior.
    McCusker J; Bigelow C; Frost R; Garfield F; Hindin R; Vickers-Lahti M; Lewis B
    Am J Public Health; 1997 Oct; 87(10):1637-44. PubMed ID: 9357345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A day treatment program in a therapeutic community setting: six-month outcomes. The Walden House Day Treatment Program.
    Guydish J; Werdegar D; Sorensen JL; Clark W; Acampora A
    J Subst Abuse Treat; 1995; 12(6):441-7. PubMed ID: 8749728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of treatment outcomes in men and women admitted to a therapeutic community.
    Messina N; Wish E; Nemes S
    Am J Drug Alcohol Abuse; 2000 May; 26(2):207-27. PubMed ID: 10852357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse relapse in Oxford House recovery homes: A survival analysis evaluation.
    Harvey R; Jason LA; Ferrari JR
    Subst Abus; 2016; 37(2):281-5. PubMed ID: 26308507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders.
    Xie H; McHugo GJ; Fox MB; Drake RE
    Psychiatr Serv; 2005 Oct; 56(10):1282-7. PubMed ID: 16215196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
    Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
    Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Outcome Study of the CASA-CHESS Smartphone Relapse Prevention Tool for Latinx Spanish-Speakers with Substance Use Disorders.
    Muroff J; Robinson W; Chassler D; López LM; Lundgren L; Guauque C; Dargon-Hart S; Stewart E; Dejesus D; Johnson K; Pe-Romashko K; Gustafson DH
    Subst Use Misuse; 2019; 54(9):1438-1449. PubMed ID: 30931681
    [No Abstract]   [Full Text] [Related]  

  • 14. Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial.
    Weisner CM; Chi FW; Lu Y; Ross TB; Wood SB; Hinman A; Pating D; Satre D; Sterling SA
    JAMA Psychiatry; 2016 Aug; 73(8):804-14. PubMed ID: 27332703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day versus inpatient treatment for cocaine dependence: an experimental comparison.
    Schneider R; Mittelmeier C; Gadish D
    J Ment Health Adm; 1996; 23(2):234-45. PubMed ID: 10172622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders.
    Moos RH; Moos BS; Andrassy JM
    Psychiatr Serv; 1999 Dec; 50(12):1577-83. PubMed ID: 10577876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.